Biopharma firm Provention Bio names CFO, chief scientific officer
Lebanon-based Provention Bio Inc. has announced two new appointments.
The clinical-stage biopharmaceutical company dedicated to sourcing, developing and commercializing novel therapeutics aimed at intercepting and preventing immune-mediated disease, Thursday announced the appointment of Andrew Drechsler...
Rutgers-Camden opens $62.5M Nursing and Science building
Camden’s growing reputation as an “eds and meds” center in the state got another big boost this week with the dedication of Rutgers-Camden’s $62.5 million Nursing and Science building.
University officials feel the 107,000-square-foot building,...
N.J. health commissioner to become hospital association CEO
The state’s health commissioner is going to be the new CEO and president of the New Jersey Hospital Association, according to a board of trustees announcement Tuesday.
Cathleen Bennett, who has served as the commissioner...
Retiring Virtua CEO describes lessons learned, changes in industry
Virtua has become a household name in parts of South Jersey, but it wasn’t always that way.
Retiring CEO Richard Miller said that, after he led the merger of two hospitals that created the new...
RWJBarnabas, CareOne announce acute to post-acute care partnership
The state’s largest health system has partnered with New Jersey's largest family-owned and -operated senior care provider to further develop an existing relationship focused on transition of acute to post-acute care.
Barry Ostrowsky, CEO and...
Eisai hires Celgene exec as SVP for Americas Commercial oncology unit
Eisai Inc. has named a new senior vice president of its Americas Commercial, Oncology Business Group.
The Tokyo-based company’s U.S. pharmaceutical subsidiary is headquartered in Woodcliff Lake.
Michael Amoroso will lead the team in creating and...
Muscle product firm names interim CEO to permanent post
MYOS RENS Technology Inc. has made its interim CEO permanent.
The Cedar Knolls-based company's products focus on muscle health and performance.
Joseph Mannello has agreed to work for an option to purchase 300,000 shares of the...
Health care institute hopes program will show if payment reform works
Is the much-touted value-based reimbursement model, in which providers get paid for care of a patient rather than per procedure, working?
It’s a question the Centers for Medicare and Medicaid Services Innovation Center is asking...
NJHA’s Ryan: New attempt to kill ACA would cost N.J. $3.9B in funds
The last-ditch attempt to replace the Affordable Care Act, a proposal by U.S. Sens. Lindsey Graham and Bill Cassidy, would cost New Jersey $3.9 billion in federal health care funds by 2026, according to...
Biologics firm Catalent makes $950M deal for drug services firm
Catalent Inc. has bought Bloomington, Indiana-based Cook Pharmica LLC for $950 million.
The Somerset-based company will pay $750 million upon closing for the integrated provider of drug substance and drug product manufacturing and related services.
The...
